Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tolerance Induction Using Autologous Regulatory T Cell Infusion and Zortress (Everolimus) in Renal Transplant Recipients: a Pilot Study

NCT03284242 is registered in ClinicalTrials.gov with Roberto Gedaly as lead sponsor.

NCT NCT03284242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03284242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tolerance Induction Using Autologous Regulatory T Cell Infusion and Zortress (Everolimus) in Renal Transplant Recipients: a Pilot Study
Lead sponsor
Roberto Gedaly
Phase
Phase 1
Overall status
Completed
Start date
March 15, 2019
Completion date
April 10, 2024
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease, kidney transplant